MPL and systemic lupus erythematosus: LaMoreaux et al[13] (2016) described 1 pediatric and 1 adult patient, with antiphospholipid antibodies, 1 with SLE who developed CAPS 1 month after treatment with the TPO-R agonist Romiplostim.